Kriba is thrilled to return to Arab Health 2025, one of the world’s premier healthcare industry events, following a successful debut in 2024.
This year, we’re showcasing our innovation, Neosonics® and Neosonics® Vitro Kidney, our non-invasive, AI powered ultrasound serous fluids white blood cell counter. Neosonics© and Neosonics© Vitro Kidney are under development. This device has not yet been approved by the FDA or CE mark authorities.
Arab Health, held annually in Dubai, is a key platform for engaging with global industry leaders, healthcare professionals, and collaborators. Last year’s edition featured over over 3,450 exhibitors and attracted more than 110,000 healthcare professional visits from 180 countries.
This year, Kriba will not only present new insights and advancements related to Neosonics® but also share exciting updates related to our mission to democratize global infection screening of serous fluids through high-resolution ultrasound technology and AI algorithms.
Join us Saeed Hall 2 Booth E56 or schedule a meeting in advance at info@kriba.ai to connect and discuss the future of early detection and monitoring of infections.
